Table 1 Baseline clinical characteristics of MM patients included in the study.
From: CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment
|  | MM patients (n = 48) |
|---|---|
Median age (range) | 72 (39–87) |
Males | 54.2 (26) |
Females | 45.8% (22) |
Stage ISS, n | Â |
I | 33% (16) |
II | 33% (16) |
III | 33% (16) |
Newly diagnosed pts | 62,5% (30) |
Resistant/refractory pts | 37,5% (18) |
Resistant/refractory patients | Â |
IP-resistant/refractory | 100% (18) |
Double-resistant/refractory (PIs and IMiDs) | 44% (8) |
